SL
Siren LLC Portfolio holdings
AUM
$1.93B
This Quarter Return
+73.94%
1 Year Return
+118.08%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.26B
AUM Growth
+$2.26B
(+13%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
6.12%
Top 10 Holdings %
Top 10 Hldgs %
48.55%
Holding
132
New
22
Increased
22
Reduced
21
Closed
14
Top Buys
| 1 |
SEPN
Septerna, Inc. Common Stock
SEPN
|
$50.4M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$38.9M |
| 3 |
Apogee Therapeutics
APGE
|
$33.9M |
| 4 |
NewAmsterdam Pharma
NAMS
|
$30.2M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$25.8M |
Top Sells
| 1 |
Scholar Rock
SRRK
|
$86.8M |
| 2 |
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
|
$30.1M |
| 3 |
Wave Life Sciences
WVE
|
$24.4M |
| 4 |
argenx
ARGX
|
$17.6M |
| 5 |
Biohaven
BHVN
|
$14.2M |
Sector Composition
| 1 | Healthcare | 92.88% |
| 2 | Technology | 3.51% |
| 3 | Communication Services | 1.85% |
| 4 | Consumer Discretionary | 0.74% |
| 5 | Real Estate | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Foghorn Therapeutics
FHTX
$286M
| $3.4M | 0.15% |
720,720
| – | – |
|
|
VIGL
77
DELISTED
Vigil Neuroscience
VIGL
| $3.38M | 0.15% |
1,991,038
| – | – |
|
|
NBIS
78
Nebius Group N.V. Class A Ordinary Shares
NBIS
$16.3B
| $3.32M | 0.15% |
+120,000
| New | +$3.32M |
|
79
Sagimet Biosciences
SGMT
$244M
| $3.26M | 0.14% |
724,771
| – | – |
|
80
Generation Bio
GBIO
$40.4M
| $3.16M | 0.14% |
2,982,733
| – | – |
|
81
TSMC
TSM
$1.2T
| $2.96M | 0.13% |
15,000
-10,000
| -40% | -$1.97M |
|
82
Freeport-McMoran
FCX
$63.7B
| $2.86M | 0.13% |
+75,000
| New | +$2.86M |
|
|
KLRS
83
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
| $2.77M | 0.12% |
6,597,167
| – | – |
|
84
Ovid Therapeutics
OVID
$91M
| $2.66M | 0.12% |
2,850,000
| – | – |
|
85
Sea Limited
SE
$110B
| $2.65M | 0.12% |
25,000
-12,500
| -33% | -$1.33M |
|
86
Elastic
ESTC
$9.04B
| $2.48M | 0.11% |
25,000
+12,000
| +92% | +$1.19M |
|
87
Qualcomm
QCOM
$173B
| $2.3M | 0.1% |
15,000
| – | – |
|
|
BIOA
88
BioAge Labs, Inc. Common Stock
BIOA
$177M
| $2.25M | 0.1% |
388,000
+88,000
| +29% | +$510K |
|
89
Black Diamond Therapeutics
BDTX
$157M
| $2.24M | 0.1% |
1,046,517
| – | – |
|
90
Regenxbio
RGNX
$451M
| $2.2M | 0.1% |
284,000
| – | – |
|
91
Tourmaline Bio
TRML
$601M
| $1.85M | 0.08% |
91,426
| – | – |
|
92
Procore
PCOR
$10.4B
| $1.5M | 0.07% |
20,000
-12,300
| -38% | -$922K |
|
93
Applied Therapeutics
APLT
$71M
| $1.4M | 0.06% |
1,633,768
| – | – |
|
94
Alphabet (Google) Class A
GOOGL
$2.57T
| $1.33M | 0.06% |
7,000
-4,000
| -36% | -$757K |
|
95
PayPal
PYPL
$67.1B
| $1.28M | 0.06% |
15,000
| – | – |
|
|
HOOK
96
DELISTED
HOOKIPA Pharma
HOOK
| $1.14M | 0.05% |
566,640
| – | – |
|
97
HCA Healthcare
HCA
$94.5B
| $1.13M | 0.05% |
+3,750
| New | +$1.13M |
|
98
KE Holdings
BEKE
$20.8B
| $1.11M | 0.05% |
60,000
-40,000
| -40% | -$737K |
|
99
Workiva
WK
$4.61B
| $1.1M | 0.05% |
+10,000
| New | +$1.1M |
|
100
Palo Alto Networks
PANW
$127B
| $1.09M | 0.05% |
6,000
+1,500
| +33% | +$273K |
|